By Sarah Williams, MHA, MPH, RD, Nerac Analyst,
Originally Published: July 31, 2018
The European Clinical Evaluation Guidance MEDDEV 2.7/1 Revision 4 updated many requirements for clinical evaluation of medical devices and provided detailed descriptions of what the Clinical Evaluation Report (CER) should encompass to assess and document safety and performance of a device. In particular, revision 4 clarifies the previously brief mention of state of the art.
This article explores how to establish and document state of the art in terms of CER requirements.
The article is free!
Simply fill in the form below, verify your email address
and you’ll be sent a link to download the article.
- 73By Donna Mitchell-Magaldi, Nerac Analyst Originally Published: February 10, 2015 It is no surprise to anyone in the medical device industry that the European Commission is working on a new regulatory framework that will in essence take the three existing directives: Directive 90/385/EEC regarding active implantable medical devices, Directive 93/42/42 regarding medical devices, and Directive…
- Clinical Literature Evaluations via an Objective Third Party Reviewer: Maintaining Compliance with the EU Medical Directives and Beyond52By Ron Sills, Nerac Analyst, and Donna Mitchell-Magaldi, Nerac Analyst Originally Published: September 26th, 2014 In 2009, the European Commission released MedDev 2.7.1 Rev.3 “Clinical Evaluation: A Guide for Manufacturers and Notified Bodies” as a supplement to the requirements of the EU Medical Device Directive 93/42/EEC. In order for medical devices to be marketed in…
- 51By Robert Zott, Director of Advisory Services Originally Published: July 18, 2018 The publication of the new Medical Device Regulation (MDR) 2017/745 in the European Journal, with its entry into force on May 25, 2017, marks the end of an eight-year period of controversy, and the beginning of a three-year transition to the most sweeping…